Debulking Surgery Combined with Low-Dose Oral Prednisolone and Azathioprine for Intractable IgG4-Related Orbital Disease: A Case Report
Open Access
Abstract
A case of intractable IgG4-related orbital disease (IgG4-ROD) was successfully treated by debulking surgery combined with low-dose prednisolone and azathioprine as maintenance therapy. A 64-year-old man visited our clinic with progressive bilateral upper eyelid swelling and right eye fullness of a year’s duration. He was previously treated with systemic corticosteroids for the IgG4-ROD and experienced a partial clinical response but relapsed upon prednisolone cessation. The patient underwent debulking surgery of the right lacrimal gland and right upper eyelid. His post-operative medication was oral prednisolone (5 mg) every other day and 50 mg azathioprine per day. The patient’s right eye remained asymptomatic during the 18 months of follow-up. Debulking surgery combined with low-dose prednisolone and azathioprine, as a maintenance therapy, is an effective and alternative treatment for the long-term control of intractable IgG4-ROD.Keywords
This publication has 15 references indexed in Scilit:
- The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective studyBMJ Open Ophthalmology, 2019
- The treatment outcomes in IgG4‐related orbital disease: a systematic review of the literatureActa Ophthalmologica, 2019
- The treatment outcomes in IgG4-related disease2018
- A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related diseaseModern Rheumatology, 2017
- Therapeutic approach to IgG4-related diseaseMedicine, 2016
- Predictors of disease relapse in IgG4-related disease following rituximabRheumatology, 2016
- International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related DiseaseArthritis & Rheumatology, 2015
- Location and frequency of lesions in patients with IgG4-related ophthalmic diseasesGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- IgG4-related orbital disease: a meta-analysis and reviewActa Ophthalmologica, 2012
- Treatment approaches to IgG4-related systemic diseaseCurrent Opinion in Rheumatology, 2011